[go: up one dir, main page]

GB201816376D0 - Diagnostic test - Google Patents

Diagnostic test

Info

Publication number
GB201816376D0
GB201816376D0 GBGB1816376.6A GB201816376A GB201816376D0 GB 201816376 D0 GB201816376 D0 GB 201816376D0 GB 201816376 A GB201816376 A GB 201816376A GB 201816376 D0 GB201816376 D0 GB 201816376D0
Authority
GB
United Kingdom
Prior art keywords
diagnostic test
diagnostic
test
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1816376.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UCL Business Ltd
Original Assignee
UCL Business Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UCL Business Ltd filed Critical UCL Business Ltd
Priority to GBGB1816376.6A priority Critical patent/GB201816376D0/en
Publication of GB201816376D0 publication Critical patent/GB201816376D0/en
Priority to PCT/GB2019/052848 priority patent/WO2020074880A1/en
Ceased legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854Immunoglobulins
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52Assays involving cytokines
    • G01N2333/521Chemokines
    • G01N2333/523Beta-chemokines, e.g. RANTES, I-309/TCA-3, MIP-1alpha, MIP-1beta/ACT-2/LD78/SCIF, MCP-1/MCAF, MCP-2, MCP-3, LDCF-1or LDCF-2
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70596Molecules with a "CD"-designation not provided for elsewhere in G01N2333/705
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/36Gynecology or obstetrics
    • G01N2800/368Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
GBGB1816376.6A 2018-10-08 2018-10-08 Diagnostic test Ceased GB201816376D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1816376.6A GB201816376D0 (en) 2018-10-08 2018-10-08 Diagnostic test
PCT/GB2019/052848 WO2020074880A1 (en) 2018-10-08 2019-10-08 Diagnostic test

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1816376.6A GB201816376D0 (en) 2018-10-08 2018-10-08 Diagnostic test

Publications (1)

Publication Number Publication Date
GB201816376D0 true GB201816376D0 (en) 2018-11-28

Family

ID=64394864

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1816376.6A Ceased GB201816376D0 (en) 2018-10-08 2018-10-08 Diagnostic test

Country Status (2)

Country Link
GB (1) GB201816376D0 (en)
WO (1) WO2020074880A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4232823A1 (en) * 2020-10-26 2023-08-30 Institut National de la Santé et de la Recherche Médicale Combination of biomarkers of preterm delivery
JP2025505035A (en) * 2022-02-10 2025-02-19 アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル Methods for predicting and monitoring spontaneous preterm birth - Patents.com

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011098783A1 (en) * 2010-02-09 2011-08-18 King's College London Markers for preterm labour and subsequent delivery
CA2825236C (en) * 2011-01-21 2022-01-18 The Governors Of The University Of Alberta Leukocyte activation and methods of use thereof
US20190339269A1 (en) * 2017-01-03 2019-11-07 The Trustees Of The University Of Pennsylvania Compositions and methods for predicting risk of preterm birth

Also Published As

Publication number Publication date
WO2020074880A1 (en) 2020-04-16

Similar Documents

Publication Publication Date Title
IL281921A (en) Software testing
CA185208S (en) Medical probe
GB201810769D0 (en) Test equipment
GB201719423D0 (en) Diagnostic tests
SG11202105529RA (en) Probe unit
SG10201911114RA (en) Test apparatus
EP3457939C0 (en) Diagnostic measurement apparatus
GB201507827D0 (en) Diagnostic test
SG11202105474UA (en) Probe unit
SG11202110914XA (en) Test device
GB2575779B (en) Testing apparatus
PL3761015T3 (en) Test body
IL267982A (en) Diagnostic
PT3775869T (en) Test device
PT3794148T (en) Diagnostic blood test
GB201818581D0 (en) Test apparatus
GB201809969D0 (en) Test apparatus
GB201816376D0 (en) Diagnostic test
GB201913035D0 (en) Test
GB201904861D0 (en) Diagnosis
GB201819508D0 (en) Non-destructive testing
HUE064848T2 (en) Diagnostic apparatus
GB201915837D0 (en) Probe
GB2566467B (en) Obtaining local area network diagnostic test results
GB201719755D0 (en) Diagnostic test

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)